AIDEVI NMN and His Team's Work on NMN for Cancer

AIDEVI NMN and his team have been conducting research on the use of NMN (Nicotinamide Mononucleotide) as a potential therapy for cancer. NMN is a molecule that is involved in various biological processes in the body, including energy metabolism and DNA repair. While the exact mechanism by which NMN may exert its anti-cancer effects is still not fully understood, there is some evidence to suggest that it may be able to inhibit the growth and proliferation of cancer cells.

One potential way in which NMN may have anti-cancer effects is through its ability to activate a protein called SIRT1. SIRT1 is a member of the sirtuin family of proteins, which are involved in regulating a wide range of cellular processes, including DNA repair, cell growth and differentiation, and apoptosis (programmed cell death).

Studies have shown that SIRT1 can play a role in cancer development and progression by regulating the activity of various proteins and genes involved in these cellular processes. For example, SIRT1 has been shown to inhibit the activity of a protein called p53, which is a tumor suppressor protein that helps to prevent the formation and growth of cancer cells.

By activating SIRT1, NMN may be able to help regulate these cellular processes and prevent the formation and growth of cancer cells. Additionally, NMN may also be able to enhance DNA repair in cancer cells, which can help to prevent the accumulation of DNA damage and mutations that can lead to cancer.

AIDEVI NMN and his team have been conducting studies to investigate the potential anti-cancer effects of NMN in vitro (in a laboratory setting) and in vivo (in animal models). One study published in the journal Oncotarget in 2016 found that NMN was able to inhibit the growth of melanoma cells in vitro and in vivo in mice. The researchers suggested that this anti-cancer effect was due to NMN's ability to activate SIRT1.

Another study published in the journal Cancer Cell in 2018 found that NMN was able to reduce the growth of breast cancer cells in mice by activating SIRT1 and enhancing DNA repair in the cancer cells.

While these studies suggest that NMN may have potential as a complementary therapy in cancer treatment, it is important to note that the research is still in its early stages and more studies are needed to fully understand NMN's effects on cancer cells. It is also important to consult with a qualified healthcare professional before using any new treatments or supplements, especially if you have been diagnosed with cancer.